Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 5/12/14  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. George F. Horner III

Wrong George F. Horner III?

Chairman

Local Address: Geneva, Switzerland
Company Description: Creabilis is a late clinical stage European biotechnology company with a primary focus in chronic pruritus (itch), a debilitating symptom of many dermatological...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • A.B.
    Belmont Abbey College
197 Total References
Web References
Creabilis - Board of Directors
www.creabilis-sa.com, 12 May 2014 [cached]
George Horner | Chairman
George Horner has over 40 years industry experience gained with both biotech and big pharma companies. He was most recently the CEO of Prestwick Pharmaceuticals, a private CNS company that was sold to Biovail Corporation and Ovation Pharmaceuticals in late 2008. Prior to joining Prestwick, George Horner was the CEO of Vicuron, a publicly listed anti-infectives company that was sold to Pfizer for $1.9 billion in 2005. George Horner also worked for Ligand Pharmaceuticals following a successful career at Abbott Laboratories where his final position was as President of the company's business in Canada. George Horner has also acted as an adviser to a number of specialist life science investors in recent years.
Creabilis - News Detail
www.creabilis-sa.com, 12 May 2014 [cached]
George F. Horner III, Chairman of Creabilis said: "We are delighted that Eliot has joined Creabilis.
Endo Pharmaceuticals Appoints New Independent Outside Director
www.prnewswire.com, 9 Aug 2006 [cached]
CHADDS FORD, Pa., Aug. 9 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals Holdings Inc. (Nasdaq: ENDP), a specialty pharmaceutical company with market leadership in pain management, today announced the appointment of George F. Horner III to its board of directors.Horner, the former chief executive officer and director of Vicuron Pharmaceuticals Inc., replaces Joseph T. O'Donnell, Jr., who has resigned.
...
"We are delighted to welcome to the Endo board an executive with the kind of broad-based pharmaceutical industry experience that George Horner brings, and we look forward to his counsel as Endo continues its growth as a leading specialty pharmaceutical company," said Peter A. Lankau, president and chief executive officer.
...
Horner was the president and chief executive officer and a member of the board of directors of Vicuron Pharmaceuticals Inc. from 1996 until its acquisition by Pfizer Inc. in September 2005.Prior to joining Vicuron, Horner was corporate vice president of Ligand Pharmaceuticals from 1993 to 1995.He also served in a number of executive positions during his 17 years at Abbott Laboratories from 1976 to 1993, including president, Canada; regional director, Latin America; general manager, Mexico; general manager, Southern Africa Region; and regional manager, Southeast Asia.Horner began his career in the pharmaceutical industry at E.R. Squibb, Inc., where he served in a number of sales and product management positions.
Endo Pharmaceuticals- Investor Relations - News Release
phx.corporate-ir.net [cached]
CHADDS FORD, Pa., Aug. 9 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals Holdings Inc. (Nasdaq: ENDP), a specialty pharmaceutical company with market leadership in pain management, today announced the appointment of George F. Horner III to its board of directors.Horner, the former chief executive officer and director of Vicuron Pharmaceuticals Inc., replaces Joseph T. O'Donnell, Jr., who has resigned.
...
"We are delighted to welcome to the Endo board an executive with the kind of broad-based pharmaceutical industry experience that George Horner brings, and we look forward to his counsel as Endo continues its growth as a leading specialty pharmaceutical company," said Peter A. Lankau, president and chief executive officer.
...
Horner was the president and chief executive officer and a member of the board of directors of Vicuron Pharmaceuticals Inc. from 1996 until its acquisition by Pfizer Inc. in September 2005.Prior to joining Vicuron, Horner was corporate vice president of Ligand Pharmaceuticals from 1993 to 1995.He also served in a number of executive positions during his 17 years at Abbott Laboratories from 1976 to 1993, including president, Canada; regional director, Latin America; general manager, Mexico; general manager, Southern Africa Region; and regional manager, Southeast Asia.Horner began his career in the pharmaceutical industry at E.R. Squibb, Inc., where he served in a number of sales and product management positions.
News from Pfizer: Pfizer to Acquire Vicuron Pharmaceuticals to Extend its Research Commitment in Anti-Infectives
www.pfizer.com, 16 June 2005 [cached]
"We believe this transaction is in the best interests of our shareholders and will enable Vicuron's two near-term products to utilize Pfizer's capabilities in order to fully achieve their potential", said George F. Horner III, President and Chief Executive Officer of Vicuron.
Other People with the name "Horner":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304